Epidemiology of hilar cholangiocarcinoma in Egypt: Single center study

Hepato-Gastroenterology

Volumn 54, Issue 78, 2007, Pages 1626-1631

  Abdel Wahab, Mohamed ^a   Mostafa, M ^a   Salah, T ^a   Fouud, A ^a   Kandeel, T ^a   Elshobary, M ^a   Fathy, O ^a   Abd Allah, T ^a   Elghawalby, N ^a   Sultan, A ^a   Ezzat, F ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

Delta Egypt; Epidemiology; HBs; HCV; Hepatocellular carcinoma; Hilar cholangiocarcinoma; Rural; Urban

Indexed keywords

TUMOR MARKER;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BLOOD ANALYSIS; CANCER RISK; CLINICAL EXAMINATION; CLINICAL FEATURE; CONTROLLED STUDY; EGYPT; ENZYME BLOOD LEVEL; FEMALE; GALLSTONE; HOSPITAL ADMISSION; HUMAN; KIDNEY FUNCTION TEST; LABORATORY TEST; LIVER FUNCTION TEST; LIVER HILUS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PRIORITY JOURNAL; RURAL AREA; SCHISTOSOMIASIS; SEROLOGY; TYPHOID FEVER; URBAN AREA;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; EGYPT; FEMALE; GALLSTONES; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; RESIDENCE CHARACTERISTICS; RURAL POPULATION; SCHISTOSOMIASIS; SEX FACTORS; TYPHOID FEVER;

EID: 35948988159     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Abdel Wahab M, Fathy O, Elghwalby N, Sultan A, Elebidy E, Abdalla T, Elshobary M, Mostafa M, Foad A, Kandeel T, Abdel Raouf A, Salah T, Abu Zeid M, Abu Elenein A, Gad Elhak N, ElFiky A, Ezzat F: Resectability and prognostic factors after resection of hilar cholangiocarcinoma. Hepatogastroenterology 2006; 53(67):5-10.
2. Klatskin G: Adenocarcinoma of the hepatic duct at its bifurcation within the porta hepatis. An unusual tumor with distinctive clinical and pathological features. Am J Med 1965; 38:241-256.
3. Nakeeb A, Pitt HA, Sohn TA, Coleman J, Abrams RA, Piantadsi S, Hruban RH, Lillemoe KD, Yeo CJ, Cameron JL: Cholangiocarcinoma: a spectrum of intrahepatic, perihilar, and distal tumors. Ann Surg 1996; 224(4):463-475.
4. Lamesch P, Weimann A, Hauss J, Pichlmayr R: Surgical treatment of intrahepatic cholangiocarcinoma. Chirugie 1997; 122(2):88-91.
5. Parker SL, Tong T, Balden S, Wingo PA: Cancer statistics, 1996.CA Cancer J Clin 1996; 46(1):5-27.
6. Lowenfels AB, Maisonneuve P: Pancreatico-biliary malignancy: prevalence and risk factors. Ann Oncol 1999; 10(4):1-3.
7. Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH: Hilar Cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998; 228(3):385-394.
8. Launois B, Reding R, Lebeau G, Buard J: Surgery for hilar cholangiocarcinoma: French experience in a collective survey of 552 extrahepatic bile duct cancers. J Hepatobiliary Pancreat Surg 2000; 7(2):128-134.
9. Parkin DM, Ohshima H, Srivatanakul P, Vatanasapt V: Cholangiocarcinoma: Epidemiology, Mechanisms of Carcinogenesis and Prevention. Cancer Epidemiol Biomarkers Prev 1993; 2(6):537-544.
10. Adkins RB Jr, Dunbar LL, McKnight WG, Farringer JL Jr: An aggressive surgical approach to bile duct cancer. Am Surg 1986; 52(3):134-139.
11. Lygidakis NJ, van der Heyde MN, van Dongen RJ, Kromhout JG, Tytqat GN, Huibregtse K: Surgical approaches for unresectable primary carcinoma of the hepatic hilus. Surg Gynecol Obstet 1988; 166(2):107-114.
12. Jarnagin WR, Fong Y, DeMatteo RP, Gonen M, Burke EC, Bondiewicz BS J, Yossef BAM, Klimstru D, Blumqart LH: Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001; 234(4):507-519.
13. Patel T: Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States. Hepatology 2001; 33(6):1353-1357.
14. Shaib YH, Davila JA, McGlynn KA, El-Serag HB: Rising incidence of intrahepatic cholangiocarcinoma in the United States: a true increase? J Hepatology 2004; 40(3):472-477.
15. Liu XF, Zhou XT, Zou SQ: An analysis of 680 cases of cholangiocarcinoma from 8 hospitals. Hepatobiliary Pancreat Dis Int 2005; 4(4):585-588.
16. Boonla C, Sripa B, Thuwajit P, Cha-On U, Puapairoj A, Miwa M, Wongkham S: MUC1 and MUC5AC mucin expression in liver fluke-associated intrahepatic cholangiocarcinoma World J Gastroenterol 2005; 11(32):4939-4946.
17. Abdel-Wahab M, el-Enein AA, Abou-Zeid M, el-Fiky A, Abdallah T, Fawzy M, Fouad A, Sultan A, Fathy O, el-Ebidy G, el-Ghawalby N, Ezzat F: Hepatocellular carcinoma in Mansoura-Egypt: experience of 385 patients at a single center. Hepatogastroenterology 2000; 47(33):663-668.
18. Okuda K: Hepatocellular carcinoma. J Hepatol 2000; 32(1):225-237.
19. Ritchie JK: Hawley PR: Carcinoma of the biliary tract associated with ulcerative colitis. Gut 1972; 13(10):840-841.
20. Shaib YH, El-Serag HB, Davila JA, Morgan R, McGlynn KA: Risk factors of intrahepatic cholangiocarcinoma in the United States: a case-control study. Gastroenterology 2005; 128(3):620-626.
21. Herman WH, Ali MA, Aubert RE, Engelgau MM Kenny SJ, Gunter EW, Malarcher AM, Brechner RJ, Wetterhall SF, DeStefano F: Diabetes mellitus in Egypt: risk factors and prevalence. Diabet Med 1995; 12(12):1126-1131.
22. Yamada S, Hosoda S, Tateno H, Kido C, Takahashi S: Survey of Thorotrast-associated liver cancers in Japan. J NatI Cancer Inst 1983; 70:31-35.
23. Chalasani N, Baluyut A, Ismail A, Zaman A, Sood G, Ghalib R, McCashland TM, Reddy KR, Zervos X, Anbari MA, Hoen H: Cholangiocarcinoma in patients with primary sclerosing cholangitis: a multicenter case-control study. Hepatology 2000; 31(1):7-11.
24. Shin HR, Lee CU, Park HJ, Seol SY, Chung JM, Choi HC, Ahn YO, Schiqemostu T: Hepatitis B and C virus, Clonorchis sinesis for the risk of liver cancer: a case-control study in Pusan, Korea. Int J Epidemiol 1996; 25(5):933-940.
25. Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, Suzuki F, Tsubota A, Arase Y, Chayama K, Murashima N, Kumada H: Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus related cirrhosis. Cancer 2000; 88(11):2471-2477.
26. Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea F, Martelli C, Savio A, Trevisi P, Nardi G: Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 2001; 12(10):959-996.
27. Yamamoto S, Kubo S, Hai S, Uenishi T, Yamamoto T, Shuto T, Takemura S, Tanaka H, Yamazaki O, Hirohashi K, Tanaka T: Hepatitis C virus infection as a likely etiology of intrahepatic cholangiocarcinoma. Cancer Sci 2004; 95(7):592-595.
28. Wiwanitkit V: Seroprevalence of hepatitis virus B seropositive in the patients with cholangiocarcinoma: a summary. Asian Pac J Cancer Prev 2005; 6(1):27-28.
29. Zou SQ, Liu XF, Guo RX, Li CL, Zhou XS, Zhu XG, Huang ZQ: The retrospective analysis of HBV and HCV infection in cholangiocarcinoma. Zhonghua Wai Ke Za Zhi 2003; 41(6):417-419.
30. Andoh H, Yasui O, Kurokawa T, Sato T: Cholangiocarcinoma coincident with schistosomiasis japonica. J Gastroenterol 2004; 39(1):64-68.
31. Darwish MA, Raouf TA, Rushdy P, Constantine NT, Rao MR, Edelman R: Risk factors associated with a high prevalence of hepatitis C virus infection in Egyptian blood donors. Am J Trop Med Hyg 1993; 49(4):440-449.
32. Madwar MA, el Tahaway M, Strickland GT: The relationship between uncomplicated schistosomiasis and hepatitis B infection. Trans R Soc Trop Med Hyg 1989; 83(2):233-236.
33. Khurana S, Dubey ML, Malla N: Association of parasitic infections and cancers. Indian J of Med Microbiolo 2005; 23(2):74-79.
34. Wahib AA, Masoud AA, Halem AA, Haseeb AN, Hassan AR, Darwish MA: Cell mediated immune response in chronic liver diseases: Schistosomal, viral and neoplastic. J Egypt Soc Parasitol 1998; 28(3):929-939.
35. Lyra LG, Reboucas G, Andrade ZA: Hepatitis B surface antigen carrier state in hepatosplenic schistosomiasis. Gastroenterology 1976; 71(4):641-645.
36. Yates SC, Hafez M, Beld M, Lukashov VV, Hassan Z, Carboni G, Khaled H, Mcmorrow M, Attia M, Goudsmit J: Hepatocellular carcinoma in Egyptians with and without a history of hepatitis B virus infection: association with hepatitis C virus (HCV) infection but not with (HCV) RNA level. Am J Trop Med Hyg 1999; 60(4):714-720.
37. Flavell DJ: Liver-fluke infection as an aetiological factor in bile-duct carcinoma of man. J Trans R Soc Trop Med Hyg 1981; 75(6):814-824.
38. Welton JC, Marr JS, Friedman SM: Association between hepatobiliary cancer and typhoid carrier state. Lancet 1979; 1(8120):791-794.
39. Caygill CP, Braddick M, Hill MJ, Knowles RL, Sharp JC: The association between typhoid infection and subsequent cancer at a number of sites. Eur J Cancer Prev 1995; 4(2):187-188.
40. El-Zayadi A, Ghoneim M, Kabil SM, el Tawil A, Sherif A, Selim O: Bile duct carcinoma in Egypt: possible etiological factors. Hepatogastroenterology 1991; 38(4):337-340.
41. Lee CC, Wu CY, Chen GH: What is the impact of coexistence of hepatolithiasis on cholangiocarcinoma? J Gastroenterol Hepatol 2002; 17(9):1015-1020.
42. Sugihara S, Nakahara T, Maruiwa M, Kojiro M, Jwai I, Tanaka M, Hirai K, Majima Y, Tanikawa K: An autopsy case with a combination of hepatocellular carcinoma and cholangiocellular carcinoma. Gan No Rinsho 1987; 33(2):205-210.
43. Nakanuma Y, Terada T, Tanaka Y, Ohta G: Are hepatolithiasis and cholangiocarcinoma aetiologically related? A morphological study of 12 cases of hepatolithiasis associated with cholangiocarcinoma. Virchows Arch A Pathol Anat Histopathol 1985; 406(1):45-58.
44. Lee KT, Liu TS: Expression of transforming growth factor betas and their signaling receptors in stone-containing intrahepatic bile ducts and cholangiocarcinoma. World J Surg 2003; 27(10):1143-1148.
45. Yalcin S: Diagnosis and management of cholangiocarcinoma: A comprehensive review. Hepatogastroenterology 2004; 51(55):4.